Published in J Clin Invest on November 01, 1984
Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J Exp Med (1989) 1.85
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest (2000) 1.74
Cationization of catalase, peroxidase, and superoxide dismutase. Effect of improved intraarticular retention on experimental arthritis in mice. J Clin Invest (1985) 1.27
Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol (2010) 1.16
Lessons from animal models of arthritis over the past decade. Arthritis Res Ther (2009) 1.10
Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw. Clin Exp Immunol (2000) 1.07
Electrical charge of the antigen determines its localization in the mouse knee joint. Deep penetration of cationic BSA in hyaline articular cartilage. Am J Pathol (1985) 1.03
Effects of murine recombinant interleukin 1 on intact homologous articular cartilage: a quantitative and autoradiographic study. Ann Rheum Dis (1988) 1.01
Cationic Yersinia antigen-induced chronic allergic arthritis in rats. A model for reactive arthritis in humans. J Clin Invest (1991) 1.01
Cationic immune complex arthritis in mice--a new model. Synergistic effect of complement and interleukin-1. Am J Pathol (1992) 0.99
The putative arthritogenic cationic 19-kilodalton antigen of Yersinia enterocolitica is a urease beta-subunit. Infect Immun (1993) 0.99
Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis. Ann Rheum Dis (1998) 0.98
Experimental arthritis in C57black/6 normal and beige (Chediak-Higashi) mice: in vivo and in vitro observations on cartilage degradation. Ann Rheum Dis (1988) 0.93
Streptococcal cell wall-induced arthritis and flare-up reaction in mice induced by homologous or heterologous cell walls. Am J Pathol (1988) 0.92
Monoclonal anti-Ia antibodies suppress the flare up reaction of antigen induced arthritis in mice. Clin Exp Immunol (1986) 0.91
Fc gamma R expression on macrophages is related to severity and chronicity of synovial inflammation and cartilage destruction during experimental immune-complex-mediated arthritis (ICA). Arthritis Res (2000) 0.91
Allergic arthritis induced by cationic antigens: relationship of chronicity with antigen retention and T-cell reactivity. Immunology (1987) 0.91
Transport and equilibrium uptake of a peptide inhibitor of PACE4 into articular cartilage is dominated by electrostatic interactions. Arch Biochem Biophys (2010) 0.90
The role and clinical implications of G6PI in experimental models of rheumatoid arthritis. Arthritis Res Ther (2004) 0.90
Circulating C3 is necessary and sufficient for induction of autoantibody-mediated arthritis in a mouse model. Arthritis Rheum (2007) 0.89
Flare-up reaction of streptococcal cell wall induced arthritis in Lewis and F344 rats: the role of T lymphocytes. Clin Exp Immunol (1990) 0.89
In vivo role of phagocytic synovial lining cells in onset of experimental arthritis. Am J Pathol (1993) 0.88
Allergic arthritis induced by cationic proteins: role of molecular weight. Immunology (1989) 0.85
Inhibition of histone/anti-histone reactivity by histone-binding serum components; differential effect on anti-H1 versus anti-H2B antibodies. Clin Exp Immunol (1994) 0.82
Electrical charge and joint inflammation. Suppression of cationic aBSA-induced arthritis with a competitive polycation. Am J Pathol (1987) 0.81
Antigen induced arthritis in beige (Chediak-Higashi) mice. Ann Rheum Dis (1990) 0.80
Interaction of polymorphonuclear leucocytes with patellar cartilage of immobilised arthritic joints: a scanning electron microscopic study. Ann Rheum Dis (1989) 0.80
Accelerated onset of collagen-induced arthritis by remote inflammation. Clin Exp Immunol (1994) 0.80
Perpetuation of inflammation associated with experimental arthritis: the role of macrophage activation by neutrophilic myeloperoxidase. Mediators Inflamm (1998) 0.79
Comparison of mobility changes with histological and biochemical changes during lipopolysaccharide-induced arthritis in the hamster. Am J Pathol (1994) 0.77
Experimental allergic arthritis in mice: effects of local enzyme therapy with native and cationic derivatives. Agents Actions (1986) 0.75
Immobilization aggravates cartilage damage during antigen-induced arthritis in mice. Attachment of polymorphonuclear leukocytes to articular cartilage. Am J Pathol (1990) 0.75
Methylated BSA mimics amyloid-related proteins and triggers inflammation. PLoS One (2013) 0.75
Particles for Local Delivery of Proteins Using Intra-Articular Route. Adv Healthc Mater (2016) 0.75
Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation. Arthritis Res Ther (2016) 0.75
The effects of immunomodulatory thymic and splenic peptides and cyclosporin A on antigen-induced arthritis in the rat. Agents Actions (1993) 0.75
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
Use of cationized ferritin as a label of negative charges on cell surfaces. J Ultrastruct Res (1972) 5.78
The chronicity of inflammation and its significance in rheumatoid arthritis. Ann Rheum Dis (1968) 3.31
Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum (1977) 3.23
The pathogenesis of chronic inflammation in experimental antigen-induced arthritis. II. Preferential localization of antigen-antibody complexes to collagenous tissues. J Exp Med (1972) 2.74
Induction of membranous nephropathy in rabbits by administration of an exogenous cationic antigen. J Clin Invest (1982) 2.12
Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum (1976) 1.94
Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol (1984) 1.80
Antigen retention in joint tissues in antigen-induced synovitis. Clin Exp Immunol (1974) 1.61
Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake. Agents Actions (1981) 1.57
Interaction of cationized antigen with rat glomerular basement membrane: in situ immune complex formation. Kidney Int (1982) 1.53
A model of in situ immune complex glomerulonephritis in the rat employing cationized ferritin. Clin Nephrol (1980) 1.51
Antigen handling in antigen-induced arthritis in mice: an autoradiographic and immunofluorescence study using whole joint sections. Am J Pathol (1982) 1.48
Cell-mediated and humoral immune responses in mice. III. Dynamic balance between delayed-type hypersensitivity and antibody response. Immunology (1977) 1.45
Quantitation of arthritis by 99mTc-uptake measurements in the mouse knee-joint: correlation with histological joint inflammation scores. Agents Actions (1984) 1.45
Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. J Clin Invest (1983) 1.40
Mechanism of trapping of immune complexes in joint collagenous tissues. Clin Exp Immunol (1975) 1.38
Isoelectric points of proteins: a table. Anal Biochem (1978) 1.34
Immune elimination and immune retention: the relationship between antigen retained in the foot and the elicitation of footpad swelling. Immunology (1980) 1.28
Preferential development by mice of delayed hypersensitivity to purified basic proteins. J Allergy (1968) 1.26
Histopathogenesis of bovine serum. Albumin-induced arthritis in the rabbit. J Rheumatol (1980) 1.15
The deposition and formation of immune complexes in collagenous tissues. Clin Immunol Immunopathol (1979) 1.11
Flare-up of antigen-induced arthritis in mice after challenge with intravenous antigen: studies on the characteristics of and mechanisms involved in the reaction. Clin Exp Immunol (1984) 1.11
Electron microscopic demonstration of immunoglobulin deposition in rheumatoid cartilage. Arthritis Rheum (1976) 1.10
The negative charge of articular cartilage surfaces. An electron microscopic study using cationized ferritin. J Bone Joint Surg Am (1982) 1.01
Antigen induced arthritis: antigen handling and chronicity of joint inflammation. Agents Actions Suppl (1982) 1.01
Antigen handling in antigen-induced joint inflammation: kinetics of a second intra-articularly injected dose of antigen in an already established antigen-induced joint inflammation. Immunology (1981) 0.98
Antigen-induced arthritis: an immunohistologic study of articular tissue and synovial fluid using the horseradish peroxidase technique. J Rheumatol (1981) 0.96
Cell-mediated and humoral immune responses in mice. I. Necessary conditions for the detection of delayed-type hypersensitivity. Int Arch Allergy Appl Immunol (1977) 0.91
The specific in vitro antibody-mediated retention of bovine serum albumin by porcine hyaline articular cartilage. Clin Exp Immunol (1983) 0.83
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum (1995) 26.94
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest (1998) 6.92
Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage (2005) 6.77
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis (1990) 5.49
Development of a disease activity score based on judgment in clinical practice by rheumatologists. J Rheumatol (1993) 4.62
The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum (2000) 4.10
Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol (1994) 3.50
Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score. Br J Rheumatol (1996) 3.36
IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J Immunol (2001) 3.32
Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis (2005) 3.25
Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum (1992) 3.05
Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra. Arthritis Rheum (1996) 2.92
Reactive arthritis associated with Campylobacter jejuni enteritis. Br Med J (1979) 2.46
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection. Immunity (2002) 2.31
Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol (1992) 2.29
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis. Ann Rheum Dis (1992) 2.26
Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum (1997) 2.21
Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol (1994) 2.18
Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum (2001) 2.11
The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells. Arthritis Rheum (2005) 2.07
Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes. J Clin Invest (1986) 2.00
Antigen-induced and zymosan-induced arthritis in mice: studies on in vivo cartilage proteoglycan synthesis and chondrocyte death. Br J Exp Pathol (1981) 1.94
Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum (2001) 1.92
Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease. Clin Exp Immunol (1983) 1.92
Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. Arthritis Rheum (2005) 1.91
Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage (2011) 1.88
Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis. Arthritis Rheum (1995) 1.86
Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J Exp Med (1989) 1.85
Characterization of the SS-B (La) antigen in adenovirus-infected and uninfected HeLa cells. EMBO J (1983) 1.83
Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol (1992) 1.82
Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol (2000) 1.80
Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med (1993) 1.80
Cross-reactivity of anti-DNA antibodies with proteoglycans. Clin Exp Immunol (1984) 1.80
Adult onset Still's disease and viral infections. Ann Rheum Dis (1988) 1.79
Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum (1993) 1.79
Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases. J Rheumatol (1992) 1.79
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis (2001) 1.78
Bone mass in patients with rheumatoid arthritis. Ann Rheum Dis (1992) 1.77
IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion. J Clin Invest (2000) 1.74
Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab Invest (1994) 1.71
Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease. Arch Intern Med (2000) 1.68
TGF-beta and osteoarthritis. Osteoarthritis Cartilage (2007) 1.66
Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Ann Intern Med (1991) 1.64
Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting. Clin Exp Immunol (1985) 1.62
Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis (1993) 1.61
Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum (1988) 1.61
Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage (2000) 1.59
Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest (2001) 1.59
Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity. Semin Arthritis Rheum (1998) 1.59
Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake. Agents Actions (1981) 1.57
Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology Research. Clin Exp Rheumatol (1993) 1.57
Infections during low-dose methotrexate treatment in rheumatoid arthritis. Semin Arthritis Rheum (1995) 1.56
No support for HLA-DQ encoded susceptibility in rheumatoid arthritis. Arthritis Rheum (1999) 1.54
Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol (1995) 1.53
Recurrent or persistent hematuria. Sign of mesangial immune-complex deposition. N Engl J Med (1974) 1.52
Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. Br J Rheumatol (1996) 1.51
Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis. Ann Rheum Dis (2006) 1.50
IgA serum levels and disease activity in ankylosing spondylitis: a prospective study. Ann Rheum Dis (1985) 1.49
Antigen handling in antigen-induced arthritis in mice: an autoradiographic and immunofluorescence study using whole joint sections. Am J Pathol (1982) 1.48
Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage (1998) 1.48
Reduced transforming growth factor-beta signaling in cartilage of old mice: role in impaired repair capacity. Arthritis Res Ther (2005) 1.47
Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis (2007) 1.47
Quantitation of arthritis by 99mTc-uptake measurements in the mouse knee-joint: correlation with histological joint inflammation scores. Agents Actions (1984) 1.45
Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis (1990) 1.44
Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol (1997) 1.44
Scl-86, a marker antigen for diffuse scleroderma. J Clin Invest (1985) 1.43
Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine (1998) 1.43
Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction. Inflamm Res (2002) 1.41
Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum (1997) 1.41
Familial vs sporadic rheumatoid arthritis (RA). A prospective study in an early RA inception cohort. Rheumatology (Oxford) (2000) 1.41
TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads. Osteoarthritis Cartilage (2009) 1.41
Degenerative knee joint lesions in mice after a single intra-articular collagenase injection. A new model of osteoarthritis. J Exp Pathol (Oxford) (1990) 1.40
Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med (1986) 1.39
Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis (2006) 1.39
Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. Br J Rheumatol (1993) 1.39
Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J Immunol (1997) 1.38
Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine. Scand J Rheumatol (1990) 1.37
Development and validation of response criteria in rheumatoid arthritis: steps towards an international consensus on prognostic markers. Br J Rheumatol (1996) 1.37
Role of tumour necrosis factor alpha in experimental arthritis: separate activity of interleukin 1beta in chronicity and cartilage destruction. Ann Rheum Dis (1999) 1.37
Methotrexate-related pulmonary complications in rheumatoid arthritis. Ann Rheum Dis (1994) 1.37
Development of osteoarthritic lesions in mice by "metabolic" and "mechanical" alterations in the knee joints. Am J Pathol (1989) 1.36
Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage (2001) 1.36
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice. Biochem Biophys Res Commun (2009) 1.36
Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis. Ann Rheum Dis (2001) 1.35